ProQR Therapeutics N.V. - Ordinary Shares (PRQR): Price and Financial Metrics

ProQR Therapeutics N.V. - Ordinary Shares (PRQR)

Today's Latest Price: $6.66 USD

0.41 (6.56%)

Updated Nov 19 6:55pm

Add PRQR to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 328 in Biotech

See all "A" rated Strong Buy stocks

PRQR Stock Summary

  • With a price/sales ratio of 45.48, ProQR Therapeutics NV has a higher such ratio than 97.04% of stocks in our set.
  • With a year-over-year growth in debt of 246.98%, ProQR Therapeutics NV's debt growth rate surpasses 93.23% of about US stocks.
  • As for revenue growth, note that PRQR's revenue has grown 1,848.03% over the past 12 months; that beats the revenue growth of 99.44% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to ProQR Therapeutics NV, a group of peers worth examining would be CYAD, MRUS, MDWD, ARPO, and CRBP.
  • PRQR's SEC filings can be seen here. And to visit ProQR Therapeutics NV's official web site, go to
PRQR Daily Price Range
PRQR 52-Week Price Range

PRQR Stock Price Chart More Charts

PRQR Price/Volume Stats

Current price $6.66
Prev. close $6.25
Day low $6.26
Day high $6.84
50-day MA $6.79
200-day MA $10.16
52-week high $20.00
52-week low $5.49
Volume 237,200
Avg. volume 216,494
Dividend yield N/A
Market Cap 328.78M

ProQR Therapeutics N.V. - Ordinary Shares (PRQR) Company Bio

ProQR Therapeutics is a biopharmaceutical company, focused on RNA medicines for the treatment of severe diseases such as cystic fibrosis and Leber's congenital amaurosis. The company was founded in 2012 and is based in Leiden, the Netherlands.

PRQR Latest News Stream

Event/Time News Detail
Loading, please wait...

PRQR Latest Social Stream

Loading social stream, please wait...

View Full PRQR Social Stream

PRQR Price Returns

1-mo -9.88%
3-mo -17.98%
6-mo -45.72%
1-year -65.20%
3-year 40.21%
5-year -55.00%
YTD -57.79%
2018 389.30%
2017 -34.18%
2016 -43.55%
2015 -59.94%
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.4999 seconds.